Article 1
The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.
Commission Implementing Regulation (EU) 2024/2781 of 31 October 2024 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 8-hydroxyquinoline, aminopyralid, azoxystrobin, Candida oleophila strain O, chlorantraniliprole, fluroxypyr, imazalil, kresoxim-methyl, metobromuron, oxyfluorfen, Paecilomyces fumosoroseus strain FE 9901, tefluthrin and terbuthylazine
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .
ANNEX Part B of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (1) in the sixth column, expiration of approval, of row 4, Azoxystrobin, the date is replaced by ‘31 May 2027’; (2) in the sixth column, expiration of approval, of row 5, Imazalil, the date is replaced by ‘31 May 2027’; (3) in the sixth column, expiration of approval, of row 8, Kresoxim-methyl, the date is replaced by ‘31 May 2027’; (4) in the sixth column, expiration of approval, of row 9, Fluroxypyr, the date is replaced by ‘15 February 2027’; (5) in the sixth column, expiration of approval, of row 10, Tefluthrin, the date is replaced by ‘31 May 2027’; (6) in the sixth column, expiration of approval, of row 11, Oxyfluorfen, the date is replaced by ‘31 May 2027’; (7) in the sixth column, expiration of approval, of row 16, Terbuthylazine, the date is replaced by ‘31 May 2027’; (8) in the sixth column, expiration of approval, of row 18, 8-hydroxyquinoline, the date is replaced by ‘31 December 2025’; (9) in the sixth column, expiration of approval, of row 37, Candida oleophila strain O, the date is replaced by ‘31 May 2027’; (10) in the sixth column, expiration of approval, of row 39, Paecilomyces fumosoroseus strain FE 9901, the date is replaced by ‘31 May 2027’; (11) in the sixth column, expiration of approval, of row 62, Chlorantraniliprole, the date is replaced by ‘31 May 2027’; (12) in the sixth column, expiration of approval, of row 76, Metobromuron, the date is replaced by ‘31 May 2027’; (13) in the sixth column, expiration of approval, of row 77, Aminopyralid, the date is replaced by ‘31 May 2027’.
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.